Imdelltra Gets Accelerated Approval for Extensive-Stage SCLC

The FDA has granted accelerated approval to Imdelltra (tarlatamab-dlle) for extensive stage small cell lung cancer.

Related Keywords

Davidp Carbone , ,James Thoracic Oncology Center ,Ohio State University Medical Center ,Drug Administration ,Ohio State University Medical ,Boxed Warning ,